BDMD

Baird Medical Investment Holdings

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 100%
Negative

Neutral
PRNewsWire
2 days ago
Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion
NEW YORK , Dec. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the appointment of Mark Saxton as Chief Executive Officer of its U.S. subsidiary.
Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion
Neutral
PRNewsWire
1 month ago
Baird Medical Enters Egyptian Market with First Successful Bone Tumor Ablation
NEW YORK , Nov. 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its official launch into the Egyptian market with the successful completion of its first procedure at the prestigious Ain Shams Specialized Hospital.
Baird Medical Enters Egyptian Market with First Successful Bone Tumor Ablation
Neutral
PRNewsWire
1 month ago
Baird Medical's MWA System Achieves Successful Medicare Reimbursement at Prominent New York Practice
NEW YORK , Oct. 27, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the clinical adoption of its MWA system at Elk Medical, a prominent private endocrinology practice in Brooklyn, New York.
Baird Medical's MWA System Achieves Successful Medicare Reimbursement at Prominent New York Practice
Neutral
PRNewsWire
1 month ago
Baird Medical Announces First Successful Liver Tumor Ablation in Bangladesh
NEW YORK , Oct. 23, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced the successful completion of its first MWA procedure in Bangladesh.
Baird Medical Announces First Successful Liver Tumor Ablation in Bangladesh
Neutral
PRNewsWire
1 month ago
Baird Medical Fosters Advanced Physician Training at International Thyroid Microwave Ablation Workshop in Malaysia
NEW YORK , Oct. 21, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful participation in the Thyroid Microwave Ablation Workshop held at the Hospital Canselor Tuanku Muhriz (HCTM) of The National University of Malaysia.
Baird Medical Fosters Advanced Physician Training at International Thyroid Microwave Ablation Workshop in Malaysia
Neutral
PRNewsWire
1 month ago
Baird Medical Champions Global Collaboration in Microwave Ablation at International Thyroid Workshop
NEW YORK , Oct. 20, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD), a global leader in minimally invasive Microwave Ablation (MWA) technology, today announced its participation in the 3rd International Workshop on Thermal Ablation of Thyroid Tumor and Hyperparathyroidism.
Baird Medical Champions Global Collaboration in Microwave Ablation at International Thyroid Workshop
Neutral
PRNewsWire
1 month ago
Baird Medical's MWA Technology Successfully Treats Large Thyroid Nodules at UCSF Health
NEW YORK , Oct. 16, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, announced its system was successfully used in two minimally invasive procedures at UCSF Health.
Baird Medical's MWA Technology Successfully Treats Large Thyroid Nodules at UCSF Health
Neutral
PRNewsWire
1 month ago
Baird Medical Highlights Johns Hopkins University Research Demonstrating Clinical and Economic Benefits of Thyroid Nodule Ablation
NEW YORK , Oct. 14, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("BAIRD MEDICAL" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, highlighted the significant findings of a cost-utility analysis conducted by researchers at Johns Hopkins University.
Baird Medical Highlights Johns Hopkins University Research Demonstrating Clinical and Economic Benefits of Thyroid Nodule Ablation
Neutral
PRNewsWire
1 month ago
Baird Medical Concludes Successful Participation at ACS Clinical Congress 2025 with Strong Interest in MWA Technology
NEW YORK , Oct. 9, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, has successfully concluded its participation in the American College of Surgeons (ACS) Clinical Congress 2025, held from October 5-7.
Baird Medical Concludes Successful Participation at ACS Clinical Congress 2025 with Strong Interest in MWA Technology
Neutral
PRNewsWire
2 months ago
Baird Medical Showcases Advanced Microwave Ablation Technology at the 2025 ACS Clinical Congress
NEW YORK , Oct. 6, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is participating in the American College of Surgeons (ACS) Clinical Congress 2025 in Chicago, IL.
Baird Medical Showcases Advanced Microwave Ablation Technology at the 2025 ACS Clinical Congress